Manfred Motz

871 total citations
20 papers, 684 citations indexed

About

Manfred Motz is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Hepatology. According to data from OpenAlex, Manfred Motz has authored 20 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Hepatology. Recurrent topics in Manfred Motz's work include SARS-CoV-2 and COVID-19 Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Manfred Motz is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Manfred Motz collaborates with scholars based in Germany, Switzerland and Slovakia. Manfred Motz's co-authors include Georg Bauer, Wolfgang Jilg, Hans Wolf, Ulrich Mohn, Jürgen J. Wenzel, Friedrich Deinhardt, Erwin Soutschek, Sonja Heinzelmann, Ryo Sumazaki and Friedhelm Struck and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Clinical Microbiology and Journal of Chromatography A.

In The Last Decade

Manfred Motz

20 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Motz Germany 15 390 346 165 83 68 20 684
B Franz Germany 12 96 0.2× 138 0.4× 104 0.6× 69 0.8× 13 0.2× 24 514
G. Diego Miralles United States 16 532 1.4× 53 0.2× 297 1.8× 118 1.4× 66 1.0× 21 1.2k
Jeffrey J. Germer United States 18 208 0.5× 535 1.5× 578 3.5× 70 0.8× 20 0.3× 41 869
Mary‐Anne Trabaud France 21 480 1.2× 975 2.8× 860 5.2× 215 2.6× 114 1.7× 55 1.6k
C C Pao Taiwan 15 186 0.5× 154 0.4× 505 3.1× 190 2.3× 9 0.1× 27 851
Natàlia Casamitjana Spain 11 112 0.3× 293 0.8× 632 3.8× 51 0.6× 13 0.2× 18 868
S. Naik India 17 171 0.4× 224 0.6× 219 1.3× 40 0.5× 7 0.1× 38 796
Verena Schlaphoff Germany 21 178 0.5× 898 2.6× 716 4.3× 93 1.1× 51 0.8× 36 1.3k
P. Hermans Belgium 14 309 0.8× 39 0.1× 150 0.9× 90 1.1× 17 0.3× 41 739
Anke Kraft Germany 20 143 0.4× 527 1.5× 604 3.7× 73 0.9× 14 0.2× 54 1.1k

Countries citing papers authored by Manfred Motz

Since Specialization
Citations

This map shows the geographic impact of Manfred Motz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Motz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Motz more than expected).

Fields of papers citing papers by Manfred Motz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Motz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Motz. The network helps show where Manfred Motz may publish in the future.

Co-authorship network of co-authors of Manfred Motz

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Motz. A scholar is included among the top collaborators of Manfred Motz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Motz. Manfred Motz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bauer, Georg, et al.. (2021). The challenge of avidity determination in SARS‐CoV‐2 serology. Journal of Medical Virology. 93(5). 3092–3104. 26 indexed citations
3.
Struck, Friedhelm, Patrick Schreiner, Sarah Schulz, et al.. (2021). Vaccination versus infection with SARS‐CoV‐2: Establishment of a high avidity IgG response versus incomplete avidity maturation. Journal of Medical Virology. 93(12). 6765–6777. 36 indexed citations
4.
Struck, Friedhelm, Patrick Schreiner, Sarah Schulz, et al.. (2021). Incomplete IgG avidity maturation after seasonal coronavirus infections. Journal of Medical Virology. 94(1). 186–196. 10 indexed citations
5.
Bauer, Georg & Manfred Motz. (2016). The Antitumor Effect of Single-domain Antibodies Directed Towards Membrane-associated Catalase and Superoxide Dismutase. Anticancer Research. 36(11). 5945–5956. 22 indexed citations
6.
Heinzelmann, Sonja, et al.. (2015). Extracellular localization of catalase is associated with the transformed state of malignant cells. Biological Chemistry. 396(12). 1339–1356. 55 indexed citations
7.
Osterman, Andreas, María Guadalupe Vizoso-Pinto, Rudolf Haase, et al.. (2012). Systematic screening for novel, serologically reactive Hepatitis E Virus epitopes. Virology Journal. 9(1). 28–28. 24 indexed citations
8.
Krumbholz, Andi, Ulrich Mohn, Jeannette Lange, et al.. (2011). Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs. Medical Microbiology and Immunology. 201(2). 239–244. 104 indexed citations
9.
Dremsek, Paul, Jürgen J. Wenzel, Reimar Johne, et al.. (2011). Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs. Medical Microbiology and Immunology. 201(2). 189–200. 130 indexed citations
10.
Neugebauer, Sebastian, et al.. (2010). A microelectrochemical sensing system for the determination of Epstein–Barr virus antibodies. Analytical and Bioanalytical Chemistry. 398(6). 2617–2623. 5 indexed citations
11.
Lehmann, Christian H.K., Hans Wolf, Jianguo Xu, et al.. (2008). A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses. Diagnostic Microbiology and Infectious Disease. 61(1). 40–48. 18 indexed citations
12.
Enders, Martin, et al.. (2007). Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection. Journal of Virological Methods. 146(1-2). 409–413. 16 indexed citations
13.
Sticherling, Michael, et al.. (2005). Comparison of Different Test Systems for Simultaneous Autoantibody Detection in Connective Tissue Diseases. Annals of the New York Academy of Sciences. 1050(1). 327–339. 37 indexed citations
14.
Bauer, Ulrike, et al.. (2005). Detection of Antibodies against Adenovirus Protein IX, Fiber, and Hexon in Human Sera by Immunoblot Assay. Journal of Clinical Microbiology. 43(9). 4426–4433. 22 indexed citations
15.
Reischl, Udo, Christian Gerdes, Manfred Motz, & Hans Wolf. (1996). Expression and purification of an Epstein-Barr virus encoded 23-kDa protein and characterization of its immunological properties. Journal of Virological Methods. 57(1). 71–85. 19 indexed citations
16.
Fuchs, Klaus, Manfred Motz, E. Schreier, et al.. (1991). Characterization of nucleotide sequences from European hepatitis C virus isolates. Gene. 103(2). 163–169. 38 indexed citations
17.
Soutschek, Erwin, et al.. (1990). Purification of a recombinantly produced transmembrane protein (gp41) of HIV I. Journal of Chromatography A. 521(2). 267–277. 11 indexed citations
18.
Marschall, Manfred, et al.. (1989). Hepatitis B virus surface antigen as a reporter of promoter activity. Gene. 81(1). 109–117. 12 indexed citations
19.
Sumazaki, Ryo, et al.. (1989). Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction. Journal of Medical Virology. 27(4). 304–308. 77 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Franz Breakdown of academic impact, for papers by G. Diego Miralles Breakdown of academic impact, for papers by Jeffrey J. Germer Breakdown of academic impact, for papers by Mary‐Anne Trabaud Breakdown of academic impact, for papers by C C Pao Breakdown of academic impact, for papers by Natàlia Casamitjana Breakdown of academic impact, for papers by S. Naik Breakdown of academic impact, for papers by Verena Schlaphoff Breakdown of academic impact, for papers by P. Hermans Breakdown of academic impact, for papers by Anke Kraft
Rankless by CCL
2026